person · Reporting owner
Hidalgo Medina Manuel
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BRISTOL MYERS SQUIBB COBMY · Entity 1662 | Director | February 01, 2026 | February 03, 2026 |
| Guardant Health, Inc.GH · Entity 3238 | Director | September 17, 2026 | September 21, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BRISTOL MYERS SQUIBB CO
Report date February 01, 2026 · Filed February 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Share UnitsSEC Table II · derivative / convertible security | Direct | 22,763.938 |
Reported balance
After 2026-02-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-02-01 · Grant · Acquired 3,996.367 · Balance 22,763.938 F1: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.
F2: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.
Guardant Health, Inc.
Report date September 17, 2026 · Filed September 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,020 |
Reported balance
After 2026-09-17 transaction · row 1
1 source rowRow 1 · 2026-09-17 · Exercise / conversion · Acquired 232 · Balance 5,020 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 5,105 |
Reported balance
After 2026-09-17 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-17 · Exercise / conversion · Disposed 232 · Balance 5,105 F1: The restricted stock unit award granted on July 17, 2024 vests over a four-year period. 25% of the shares subject to such award vested on July 17, 2025 and the remaining 75% vests monthly for the three-year period thereafter. F2: Not applicable for Restricted Stock Units. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock unit award granted on July 17, 2024 vests over a four-year period. 25% of the shares subject to such award vested on July 17, 2025 and the remaining 75% vests monthly for the three-year period thereafter.
F2: Not applicable for Restricted Stock Units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 17, 2025 Filed Sep 18, 2025 20:33 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 232 | $0.00 | $0.00 |
DisclosureSEC source: 0001865525-25-000006 · wk-form4_1758227632.xml · nonDerivative · entry 1 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,083 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 12, 2025 Filed Sep 15, 2025 21:09 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 2,165 | $54.16 | $117,250.77 |
DisclosureSEC source: 0001865525-25-000004 · wk-form4_1757970581.xml · nonDerivative · entry 1 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 851 F1 · price: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $54.1501 to $54.1651. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 17, 2025 Filed Aug 18, 2025 21:44 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 232 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000258 · wk-form4_1755553459.xml · derivative · entry 2 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,121 Underlying: Common Stock · 232 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock unit granted on July 17, 2024 vests over a four-year period. 25% of the shares subject to such award vested on the one-year anniversary of July 17, 2024 and the remaining 75% vests monthly for the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| August 17, 2025 Filed Aug 18, 2025 21:44 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 232 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000258 · wk-form4_1755553459.xml · nonDerivative · entry 1 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,016 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 17, 2025 Filed Jul 18, 2025 21:22 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 2,784 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000235 · wk-form4_1752873764.xml · derivative · entry 2 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,353 Underlying: Common Stock · 2,784 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock unit granted on July 17, 2024 vests over a four-year period. 25% of the shares subject to such award will vest on the one-year anniversary of July 17, 2024, and the remaining 75% vests monthly for the three-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| July 17, 2025 Filed Jul 18, 2025 21:22 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 2,784 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000235 · wk-form4_1752873764.xml · nonDerivative · entry 1 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,784 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 18, 2025 Filed Jun 20, 2025 21:31 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRestricted Stock Units · Derivative | 4,203 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-25-000197 · wk-form4_1750455066.xml · derivative · entry 2 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,203 Underlying: Common Stock · 4,203 shares Expires not disclosed F2 · derivative.exercise_date: The restricted stock units vest in full on the one-year anniversary of the grant date, June 18, 2025 or the date of the next year annual stockholders meeting, whichever is earlier. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| June 18, 2025 Filed Jun 20, 2025 21:31 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantStock Option (Right to Buy) · Derivative | 6,833 | $0.00 Strike: $50.57 | $0.00 |
DisclosureSEC source: 0001576280-25-000197 · wk-form4_1750455066.xml · derivative · entry 1 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,833 Underlying: Common Stock · 6,833 shares Expires 2035-06-18 F1 · derivative.exercise_date: The stock option vests in full on the one-year anniversary of the grant date, June 18, 2025 or the date of the next year annual stockholders meeting, whichever is earlier. Read SEC document |
| February 01, 2025 Filed Feb 5, 2025 00:16 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 3,562.341 | $58.95 | $210,000.00 |
DisclosureSEC source: 0000014272-25-000022 · wk-form4_1738714558.xml · derivative · entry 1 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,835.638 Underlying: Common Stock, $0.10 par value · 3,562.341 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| July 17, 2024 Filed Jul 19, 2024 22:26 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRestricted Stock Units · Derivative | 11,137 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000182 · wk-form4_1721427991.xml · derivative · entry 2 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,137 Underlying: Common Stock · 11,137 shares Expires not disclosed F2 · derivative.exercise_date: The restricted stock unit granted on July 17, 2024 vests over a four-year period. 25% of the shares subject to such award will vest on the one-year anniversary of July 17, 2024, and the remaining 75% vests monthly for the three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| July 17, 2024 Filed Jul 19, 2024 22:26 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantStock Option (Right to Buy) · Derivative | 17,029 | $0.00 Strike: $32.55 | $0.00 |
DisclosureSEC source: 0001576280-24-000182 · wk-form4_1721427991.xml · derivative · entry 1 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,029 Underlying: Common Stock · 17,029 shares Expires 2034-07-17 F1 · derivative.exercise_date: The stock option granted on July 17, 2024 vests over a four-year period. 25% of the shares subject to such award will vest on the one-year anniversary of July 17, 2024, and the remaining 75% vests monthly for the three-year period thereafter. Read SEC document |
| February 01, 2024 Filed Feb 6, 2024 00:21 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 4,314.773 | $48.67 | $210,000.00 |
DisclosureSEC source: 0000014272-24-000030 · wk-form4_1707178847.xml · derivative · entry 1 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,616.16 Underlying: Common Stock, $0.10 par value · 4,314.773 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 22:38 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 164.442 | $51.31 | $8,437.52 |
DisclosureSEC source: 0000014272-24-000008 · wk-form4_1704321470.xml · derivative · entry 1 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,188.12 Underlying: Common Stock, $0.10 par value · 164.442 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| February 01, 2023 Filed Feb 4, 2023 00:17 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 2,807.806 | $71.23 | $200,000.02 |
DisclosureSEC source: 0000014272-23-000030 · wf-form4_167546983917971.xml · derivative · entry 1 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,769.483 Underlying: Common Stock, $0.10 par value · 2,807.806 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 31, 2022 Filed Jan 4, 2023 22:24 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 117.269 | $71.95 | $8,437.50 |
DisclosureSEC source: 0000014272-23-000014 · wf-form4_167287104945943.xml · derivative · entry 1 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,914.348 Underlying: Common Stock, $0.10 par value · 117.269 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2022 Filed Oct 5, 2022 01:12 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 118.688 | $71.09 | $8,437.53 |
DisclosureSEC source: 0000014272-22-000187 · wf-form4_166493204951387.xml · derivative · entry 1 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,757.009 Underlying: Common Stock, $0.10 par value · 118.688 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 20:30 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 97.403 | $77.00 | $7,500.03 |
DisclosureSEC source: 0000014272-22-000160 · wf-form4_165705300313566.xml · derivative · entry 1 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,589.451 Underlying: Common Stock, $0.10 par value · 97.403 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 22:15 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 102.698 | $73.03 | $7,500.03 |
DisclosureSEC source: 0000014272-22-000108 · wf-form4_164911049423449.xml · derivative · entry 1 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,452.829 Underlying: Common Stock, $0.10 par value · 102.698 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 23:02 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 3,067.955 | $65.19 | $199,999.99 |
DisclosureSEC source: 0000014272-22-000035 · wf-form4_164392933198331.xml · derivative · entry 1 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,350.131 Underlying: Common Stock, $0.10 par value · 3,067.955 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 31, 2021 Filed Jan 4, 2022 23:19 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 115.277 | $62.35 | $7,187.52 |
DisclosureSEC source: 0000014272-22-000011 · wf-form4_164133835430648.xml · derivative · entry 1 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,232.837 Underlying: Common Stock, $0.10 par value · 115.277 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 20:31 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 121.472 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-21-000218 · wf-form4_163312024987329.xml · derivative · entry 1 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,116.248 Underlying: Common Stock, $0.10 par value · 121.472 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 30, 2021 Filed Jul 1, 2021 21:13 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 35.461 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-21-000173 · wf-form4_162517397238754.xml · derivative · entry 1 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,994.52 Underlying: Common Stock, $0.10 par value · 35.461 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 20:43 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 1,959.059 | $65.10 | $127,534.74 |
DisclosureSEC source: 0000014272-21-000140 · wf-form4_162275291539348.xml · derivative · entry 1 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,959.059 Underlying: Common Stock, $0.10 par value · 1,959.059 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · shares: Represents pro rata portion of the 2021 annual Deferred Share Unit awards granted to the Company's directors. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.